cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2018.11.10208cardio-314Research ArticleНОВОСТИ НАУЧНОЙ ЖИЗНИКонгресс Европейского общества клрдиологов (Барселона, 2017 г.): результаты важнейших клинических исследованийCongress of the European Society of Cardiology (Barcelona, 2017): Results of the Most Important Clinical TrialsКанорскийС. Г.KanorskiiS. G.

Краснодар

Kanorskii Sergey G. - MD, professor.

Krasnodar

kanorskysg@mail.ruМамедовМ. Н.MamedovM. N.

Москва

Moscow

ОгановР. Г.OganovR. G.

Москва

Moscow

ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава РоссииРоссияKuban State Medical UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр профилактической медицины» Минздрава РоссииРоссияNational Research Center for Preventive MedicineRussian Federation20182411201858113540Copyright © Kardiomag, 20182018KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/314

Представлен отчет о четырех научных сессиях Hot Line: Late-Breaking Clinical Trials Конгресса Европейского общества кардиологов 2017 г., посвященных результатам новых клинических исследований в кардиологии.

A report was presented on all four Hot Line: Late-Breaking Clinical Trials sessions of the European Society of Cardiology Congress 2017 on the results of new clinical research in cardiology.

кардиологияклинические исследованиясессии Hot Linecardiologyclinical trialsHot Line sessionsReferencesEikelboom J. W., Connolly S.J., Bosch J. et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017 Aug 27. [Epub ahead of print].Eikelboom J. W., Connolly S.J., Bosch J. et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017 Aug 27. [Epub ahead of print].Ridker P. M., Everett B. M., Thuren T. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377 (12):1П9-Ш1.Ridker P. M., Everett B. M., Thuren T. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377 (12):1П9-Ш1.Townsend R. R., Mahfoud F., Kandzari D. E. et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Aug 25. [Epub ahead of print].Townsend R. R., Mahfoud F., Kandzari D. E. et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Aug 25. [Epub ahead of print].Vinereanu D., Lopes R. D., Bahit M. C. et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017 Aug 25. [Epub ahead of print].Vinereanu D., Lopes R. D., Bahit M. C. et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017 Aug 25. [Epub ahead of print].Lindholt J. S., Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017 Aug 25. [Epub ahead of print].Lindholt J. S., Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017 Aug 25. [Epub ahead of print].Ray K. K., Landmesser U., Leiter L. A. et al. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. N Engl J Med 2017;376 (15):1430-1440.Ray K. K., Landmesser U., Leiter L. A. et al. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. N Engl J Med 2017;376 (15):1430-1440.Hofmann R., James S. K., Jernberg T. et al. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017;377 (13):1240-1249.Hofmann R., James S. K., Jernberg T. et al. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017;377 (13):1240-1249.Ference B. A., Kastelein J.J. P., Ginsberg H. N. et al. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA 2017;318 (10):947-956.Ference B. A., Kastelein J.J. P., Ginsberg H. N. et al. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA 2017;318 (10):947-956.Ruschitzka F., Borer J. S., Krum H. et al. Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients With Arthritis Eur Heart J 2017 Aug 28. [Epub ahead of print].Ruschitzka F., Borer J. S., Krum H. et al. Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients With Arthritis Eur Heart J 2017 Aug 28. [Epub ahead of print].HPS3/TIMI55-REVEAL Collaborative Group. Effects of Anace-trapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017;377 (13):1217-1227.HPS3/TIMI55-REVEAL Collaborative Group. Effects of Anace-trapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017;377 (13):1217-1227.

The authors declare that there are no conflicts of interest present.